Coverage of "Scribe therapeutics" on Cryptosearcher: the stories and the context behind them.
Scribe Therapeutics raised $129 million in its Nasdaq IPO, with shares jumping 67% on debut. Their epigenetic gene silencing approach and partnerships with pharma giants highlight growing biotech investor interest.
July 24, 2026
